Effects of methylphenidate on cognitive function and gait in patients with Parkinson's disease: a pilot study
- PMID: 16518128
- DOI: 10.1097/00002826-200601000-00005
Effects of methylphenidate on cognitive function and gait in patients with Parkinson's disease: a pilot study
Abstract
Twenty-one patients with Parkinson's disease were studied before and 2 h after the administration of a single dose of 20 mg of methylphenidate. In response to methylphenidate, attention significantly improved, whereas memory and visual-spatial performance were unchanged. Gait speed, stride time variability, and Timed Up and Go times (demonstrated measures of fall risk) significantly improved. These findings suggest a new potential pharmacologic means of enhancing mobility and decreasing fall risk in Parkinson's disease.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical